We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
WHO Approves Ebola Assay
News

WHO Approves Ebola Assay

WHO Approves Ebola Assay
News

WHO Approves Ebola Assay

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "WHO Approves Ebola Assay "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The World Health Organization has added Cepheid's Xpert Ebola assay to its list of Ebola diagnostics eligible for WHO procurement, Cepheid said today.

Cepheid's Ebola test runs on its GeneXpert system, of which more than 8,000 are currently deployed globally. The assay uses RT-qPCR and, like all of Cepheid's molecular diagnostic tests, is cartridge-based, making it less prone to contamination and better suited for staff with minimal formal laboratory training, WHO noted in a statement.

Xpert Ebola joins three other tests on WHO's list of in vitro diagnostics eligible for procurement in Ebola-affected countries: Shanghai ZJ Bio-Tech's Liferiver Ebola kit and Altona Diagnostics' RealStar Filovirus Screen kit, both also RT-qPCR tests; and a rapid antigen test kit called ReEBOV.

In March, Cepheid's Xpert Ebola test received Emergency Use Authorization from the US Food and Drug Administration for use by CLIA moderate- and high-complexity laboratories or similarly qualified non-US laboratories.

Advertisement